Replies to post #209 on TScan Therapeutics Inc (TCRX)

[jondoeuk]

Not that I'm aware. I know of a PhI/II (n=20) IIT testing an auto MAGE-C2 TCR-T in melanoma and H&N cancers with valproic acid and azacytidine https://journals.aai.org/jimmunol/article/197/6/2541/106100/MAGE-C2-Specific-TCRs-Combined-with-Epigenetic

Some years ago GSK presented this (before handing back to ADAP) https://jitc.bmj.com/content/8/Suppl_3/A60.2